Literature DB >> 3877350

Genetic analysis of subacute (de Quervain's) thyroiditis.

H Goto, H Uno, H Tamai, K Kuma, Y Hayashi, S Matsubayashi, T Sasazuki.   

Abstract

A weak association between subacute (de Quervain's) thyroiditis and HLA-DRw8 (relative risk = 2.19, X2 = 3.86) was observed. However, the association was not statistically significant if p value was corrected. Since it was confirmed that the association of subacute thyroiditis with HLA-B35 was primary, and since this association was extremely strong, the two models (dominant and recessive) for the effect of an HLA-linked gene which has a major effect on the pathogenesis of subacute thyroiditis were tested by the method described by Thomson & Bodmer using the frequency of HLA-B35 in the patients. The data most fit to the recessive model for the HLA-linked major gene involved in subacute thyroiditis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877350     DOI: 10.1111/j.1399-0039.1985.tb00942.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  4 in total

1.  High prevalence of subacute thyroiditis during summer season in Italy.

Authors:  E Martino; L Buratti; L Bartalena; S Mariotti; C Cupini; F Aghini-Lombardi; A Pinchera
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

2.  Sonographic Pattern of Subacute Thyroiditis Is HLA-Dependent.

Authors:  Magdalena Stasiak; Bogusław Tymoniuk; Zbigniew Adamczewski; Bartłomiej Stasiak; Andrzej Lewiński
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-23       Impact factor: 5.555

3.  Subacute Thyroiditis is Associated with HLA-B*18:01, -DRB1*01 and -C*04:01-The Significance of the New Molecular Background.

Authors:  Magdalena Stasiak; Bogusław Tymoniuk; Renata Michalak; Bartłomiej Stasiak; Marek L Kowalski; Andrzej Lewiński
Journal:  J Clin Med       Date:  2020-02-16       Impact factor: 4.241

Review 4.  New aspects in the pathogenesis and management of subacute thyroiditis.

Authors:  Magdalena Stasiak; Andrzej Lewiński
Journal:  Rev Endocr Metab Disord       Date:  2021-05-05       Impact factor: 6.514

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.